Apart from that, IGFBP3 contributes to the increasing incidence of PCa, is associated with unfavorable health outcomes, and is overexpressed in cell lines immune to Olaparib [85,86,87]. The gene discussed is IGFBP3; the disease is posterior cortical atrophy.